GC Biopharma Corp.

KOSE:A006280 Stock Report

Market Cap: ₩1.9t

GC Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of A006280?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme3,8470.0337%
Individual Insiders108,7200.953%
Institutions1,985,35717.4%
General Public3,464,77230.4%
Public Companies5,850,48251.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 69.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
51.3%
Green Cross Holdings Corporation
5,850,482₩988.7b0%no data
10.3%
National Pension Service
1,175,570₩198.7b0.03%0.07%
1.8%
The Vanguard Group, Inc.
205,955₩34.8b-0.28%no data
0.81%
BlackRock, Inc.
92,905₩15.7b0.62%no data
0.69%
Norges Bank Investment Management
78,707₩13.3b0%no data
0.61%
Dimensional Fund Advisors LP
69,748₩11.8b-0.14%no data
0.58%
Il-Sup Huh
66,173₩11.2b0%no data
0.58%
Samsung Asset Management Company, Ltd.
65,660₩11.1b0%0.04%
0.45%
Mogam Science Scholarship Foundation., Endowment Arm
50,910₩8.6b0%no data
0.37%
Bessemer Investment Management LLC
42,263₩7.1b0%0.01%
0.3%
Mirae Asset Global Investments Co., Ltd.
34,552₩5.8b0%no data
0.25%
Eun-Cheol Hur
29,014₩4.9b0%no data
0.16%
Polunin Capital Partners Limited
18,261₩3.1b0%0.23%
0.16%
SHINYOUNG Asset Management Co., Ltd.
17,797₩3.0b-26.7%0.11%
0.14%
KB Asset Management Co., Ltd.
15,414₩2.6b-11%0.02%
0.12%
Charles Schwab Investment Management, Inc.
13,412₩2.3b-0.25%no data
0.094%
Handelsbanken Asset Management
10,734₩1.8b-0.53%no data
0.092%
Yong-Tae Park
10,455₩1.8b0%no data
0.079%
State Street Global Advisors, Inc.
8,962₩1.5b-0.75%no data
0.077%
Mellon Investments Corporation
8,735₩1.5b-2.14%no data
0.064%
Kyobo AXA Investment Managers Co., Ltd.
7,324₩1.2b7.99%0.08%
0.061%
Franklin Resources, Inc.
6,928₩1.2b1.11%no data
0.05%
NH-Amundi Asset Management
5,713₩965.6m0%0.03%
0.045%
Caisse de dépôt et placement du Québec
5,118₩864.9m0%no data
0.041%
Legal & General Investment Management Limited
4,645₩785.0m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 07:57
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GC Biopharma Corp. is covered by 27 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
In Pil KimCape Investment & Securities Co., Ltd.
David LeeCLSA
Sunghwan KimCredit Suisse